Huang Yaqing, Zhu Qinchao, Zhu Yang, Valencak Teresa G, Han Ying, Ren Tanchen, Guo Chengchen, Ren Daxi
Institute of Dairy Science, College of Animal Sciences, Zhejiang University, Hangzhou 310027, China.
MOE Key Laboratory of Macromolecular Synthesis and Functionalization, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou 310027, China.
ACS Omega. 2023 Dec 29;9(1):401-412. doi: 10.1021/acsomega.3c05793. eCollection 2024 Jan 9.
Although both the function and biocompatibility of protein-based biomaterials are better than those of synthetic materials, their usage as medical material is currently limited by their high costs, low yield, and low batch-to-batch reproducibility. In this article, we show how α-lactalbumin (α-LA), rich in tryptophan, was used to produce a novel type of naturally occurring, protein-based biomaterial suitable for wound dressing. To create a photo-cross-linkable polymer, α-LA was methacrylated at a 100-g batch scale with >95% conversion and 90% yield. α-LAMA was further processed using photo-cross-linking-based advanced processing techniques such as microfluidics and 3D printing to create injectable hydrogels, monodispersed microspheres, and patterned scaffolds. The obtained α-LAMA hydrogels show promising biocompatibility and degradability during in vivo testing. Additionally, the α-LAMA hydrogel can accelerate post-traumatic wound healing and promote new tissue regeneration. In conclusion, cheap and safe α-LAMA-based biomaterials could be produced, and they have a beneficial effect on wound healing. As a result, there may arise a potential partnership between the dairy industry and the development of pharmaceuticals.
尽管基于蛋白质的生物材料的功能和生物相容性均优于合成材料,但其作为医用材料的应用目前受到高成本、低产量和低批次间重现性的限制。在本文中,我们展示了富含色氨酸的α-乳白蛋白(α-LA)如何用于制备一种适用于伤口敷料的新型天然存在的、基于蛋白质的生物材料。为了制备可光交联的聚合物,α-LA以100克批次规模进行甲基丙烯酸酯化,转化率>95%,产率90%。α-LAMA进一步使用基于光交联的先进加工技术(如微流体和3D打印)进行处理,以制备可注射水凝胶、单分散微球和图案化支架。所获得的α-LAMA水凝胶在体内测试中显示出良好的生物相容性和可降解性。此外,α-LAMA水凝胶可以加速创伤后伤口愈合并促进新组织再生。总之,可以生产出廉价且安全的基于α-LAMA的生物材料,它们对伤口愈合具有有益作用。因此,乳制品行业与药物开发之间可能会形成潜在的合作关系。